(Q37483616)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19444607%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

review article

1 reference

title

Modulation of alpha-synuclein aggregation by dopamine: a review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19444607%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19444607%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

author name string

Su Ling Leong

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19444607%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Kevin Jeffrey Barnham

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19444607%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Chi Le Lan Pham

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19444607%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

publication date

15 May 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19444607%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

published in

Neurochemical Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19444607%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19444607%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19444607%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

page(s)

1838-1846

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19444607%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11064-009-9986-8

28 January 2020

exact match

0 references

cites work

Non-Abeta component of Alzheimer's disease amyloid (NAC) revisited. NAC and alpha-synuclein are not associated with Abeta amyloid.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11064-009-9986-8

Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease

21 January 2018

1 reference

12 December 2020

Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils

1 reference

12 December 2020

Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct

1 reference

12 December 2020

Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation

1 reference

12 December 2020

Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease

1 reference

12 December 2020

Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins

1 reference

12 December 2020

Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure

1 reference

12 December 2020

Dopamine Affects the Stability, Hydration, and Packing of Protofibrils and Fibrils of the Wild Type and Variants of α-Synuclein†

1 reference

12 December 2020

The Lewy body in Parkinson's disease: molecules implicated in the formation and degradation of alpha-synuclein aggregates

1 reference

12 December 2020

Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system

1 reference

12 December 2020

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease

1 reference

12 December 2020

Interaction of alpha-synuclein and dopamine metabolites in the pathogenesis of Parkinson's disease: a case for the selective vulnerability of the substantia nigra

1 reference

12 December 2020

Aggregation of alpha-synuclein by DOPAL, the monoamine oxidase metabolite of dopamine

1 reference

12 December 2020

3,4-Dihydroxyphenylacetaldehyde and hydrogen peroxide generate a hydroxyl radical: possible role in Parkinson's disease pathogenesis

1 reference

12 December 2020

Cytosolic catechols inhibit alpha-synuclein aggregation and facilitate the formation of intracellular soluble oligomeric intermediates.

1 reference

12 December 2020

Kinetic and structural analysis of the early oxidation products of dopamine: analysis of the interactions with alpha-synuclein.

1 reference

12 December 2020

A role for alpha-synuclein in the regulation of dopamine biosynthesis

1 reference

12 December 2020

Conformational properties of alpha-synuclein in its free and lipid-associated states

1 reference

12 December 2020

Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis

1 reference

12 December 2020

Stabilization of partially folded conformation during alpha-synuclein oligomerization in both purified and cytosolic preparations

1 reference

12 December 2020

Dopamine and the dopamine oxidation product 5,6-dihydroxylindole promote distinct on-pathway and off-pathway aggregation of alpha-synuclein in a pH-dependent manner

1 reference

12 December 2020

Nitration inhibits fibrillation of human α‐synuclein in vitro by formation of soluble oligomers

1 reference

12 December 2020

Dopamine differentially induces aggregation of A53T mutant and wild type alpha-synuclein: insights into the protein chemistry of Parkinson's disease

1 reference

12 December 2020

alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease

1 reference

12 December 2020

Dopamine covalently modifies and functionally inactivates parkin

1 reference

12 December 2020

Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases

1 reference

12 December 2020

Neurodegenerative disease: amyloid pores from pathogenic mutations.

1 reference

12 December 2020

Role of individual methionines in the fibrillation of methionine-oxidized alpha-synuclein

1 reference

12 December 2020

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

1 reference

12 December 2020

alpha-Synuclein locus triplication causes Parkinson's disease

1 reference

12 December 2020

Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease.

1 reference

12 December 2020

Effect of familial Parkinson's disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human alpha-synuclein

1 reference

12 December 2020

Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro

1 reference

12 December 2020

Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles.

1 reference

12 December 2020

Inhibition of fibrillization and accumulation of prefibrillar oligomers in mixtures of human and mouse alpha-synuclein

1 reference

12 December 2020

1 reference

12 December 2020

Different species of alpha-synuclein oligomers induce calcium influx and seeding.

1 reference

12 December 2020

Reaction of oxidized dopamine with endogenous cysteine residues in the human dopamine transporter.

1 reference

12 December 2020

The relevance of iron in the pathogenesis of Parkinson's disease.

1 reference

12 December 2020

At low concentrations, 3,4-dihydroxyphenylacetic acid (DOPAC) binds non-covalently to alpha-synuclein and prevents its fibrillation

1 reference

12 December 2020

Tyrosine hydroxylase is inactivated by catechol-quinones and converted to a redox-cycling quinoprotein: possible relevance to Parkinson's disease.

1 reference

12 December 2020

Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins

1 reference

12 December 2020

The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia

1 reference

12 December 2020

Dopamine, in the presence of tyrosinase, covalently modifies and inactivates tyrosine hydroxylase.

1 reference

12 December 2020

Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation

1 reference

12 December 2020

alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies

1 reference

12 December 2020

Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes

1 reference

12 December 2020

Effects of nitration on the structure and aggregation of alpha-synuclein

1 reference

12 December 2020

Dopamine and L-dopa disaggregate amyloid fibrils: implications for Parkinson's and Alzheimer's disease

1 reference

12 December 2020

The E46K mutation in alpha-synuclein increases amyloid fibril formation.

1 reference

12 December 2020

Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid

1 reference

12 December 2020

Methionine oxidation inhibits fibrillation of human alpha-synuclein in vitro

1 reference

12 December 2020

Cellular oligomerization of alpha-synuclein is determined by the interaction of oxidized catechols with a C-terminal sequence

1 reference

12 December 2020

Formation of dopamine-mediated alpha-synuclein-soluble oligomers requires methionine oxidation

1 reference

12 December 2020

Accelerated oligomerization by Parkinson's disease linked alpha-synuclein mutants

1 reference

12 December 2020

Formation of a High Affinity Lipid-Binding Intermediate during the Early Aggregation Phase of α-Synuclein†

1 reference

12 December 2020

Alpha-synuclein in Lewy bodies

1 reference

12 December 2020

Alpha-synuclein overexpression in PC12 and chromaffin cells impairs catecholamine release by interfering with a late step in exocytosis

1 reference

12 December 2020

Molecular characterization of the dopamine transporter.

1 reference

12 December 2020

Dependence of alpha-synuclein aggregate morphology on solution conditions

1 reference

12 December 2020

Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy

1 reference

12 December 2020

Alpha-synuclein locus duplication as a cause of familial Parkinson's disease

1 reference

12 December 2020

Inhibition of alpha-synuclein fibrillization by dopamine is mediated by interactions with five C-terminal residues and with E83 in the NAC region

1 reference

12 December 2020

Dopamine promotes alpha-synuclein aggregation into SDS-resistant soluble oligomers via a distinct folding pathway

1 reference

12 December 2020

A broken alpha -helix in folded alpha -Synuclein

1 reference

12 December 2020

Expression of mutant alpha-synuclein causes increased susceptibility to dopamine toxicity

1 reference

12 December 2020

A hydrophobic stretch of 12 amino acid residues in the middle of alpha-synuclein is essential for filament assembly.

1 reference

12 December 2020

Vesicle permeabilization by protofibrillar alpha-synuclein is sensitive to Parkinson's disease-linked mutations and occurs by a pore-like mechanism.

1 reference

12 December 2020

Cell-produced alpha-synuclein oligomers are targeted to, and impair, the 26S proteasome

1 reference

12 December 2020

Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders

1 reference

12 December 2020

Staging of brain pathology related to sporadic Parkinson's disease

1 reference

12 December 2020

Inhibition of alpha-synuclein fibrillization by dopamine analogs via reaction with the amino groups of alpha-synuclein. Implication for dopaminergic neurodegeneration

1 reference

12 December 2020

Neuromelanin of the substantia nigra: a neuronal black hole with protective and toxic characteristics

1 reference

12 December 2020

Evidence for a partially folded intermediate in alpha-synuclein fibril formation

1 reference

12 December 2020

Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein

1 reference

12 December 2020

Annular alpha-synuclein oligomers are potentially toxic agents in alpha-synucleinopathy. Hypothesis

1 reference

12 December 2020

The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method

1 reference

12 December 2020

Reversible inhibition of alpha-synuclein fibrillization by dopaminochrome-mediated conformational alterations.

1 reference

12 December 2020

10.1007/S11064-009-9986-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19444607%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference